Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Aspen Pharmacare Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

(-) Cancellation by sponsor (100)
ARTG (530)
Cancellation or suspension (102)
Prescription medicine registration (9)
Australian public assessment report (AusPar) (4)

Date

2025 (9)
2024 (47)
2023 (2)
2022 (13)
2021 (5)
2020 (2)
2019 (5)
2018 (1)
2017 (7)
2016 (7)
2015 (2)

Search

Filters applied:

Cancellation by sponsor

Clear all

Sponsor content

100 result(s) found, displaying 41 to 50

ASPEN-levothyroxine levothyroxine sodium 200 microgram tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
ASPEN-levothyroxine levothyroxine sodium 75 micrograms tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
ASPEN-levothyroxine levothyroxine sodium 50 microgram tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
ASPEN METHADONE TABLETS methadone hydrochloride 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
ASPEN-levothyroxine levothyroxine sodium 100 microgram tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
LITHSPEN lithium carbonate 250 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
FUNGLOZ amphotericin B (amphotericin) 10mg lozenge bottle Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
CODPHOS codeine phosphate hemihydrate 30 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
MERCAPT mercaptopurine monohydrate 50 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd
LITHQUIL SR lithium carbonate 450 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2024

Cancellation by sponsor

Requested by Aspen Pharmacare Australia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.